Identification of pyrrolo[3′,4’:3,4]cyclohepta[1,2-d][1,2]oxazoles as promising new candidates for the treatment of lymphomas-Reference-Cited by-同舟云学术

Identification of pyrrolo[3′,4’:3,4]cyclohepta[1,2-d][1,2]oxazoles as promising new candidates for the treatment of lymphomas

Published:2023-06 Issue: Volume:254 Page:115372
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Barreca Marilia,Spanò Virginia,Rocca Roberta,Bivacqua Roberta,Gualtieri Gianmarco,Raimondi Maria Valeria,Gaudio Eugenio,Bortolozzi Roberta,Manfreda Lorenzo,Bai Ruoli,Montalbano Alessandra,Alcaro Stefano,Hamel Ernest,Bertoni Francesco,Viola Giampietro,Barraja Paola

Funder

National Cancer Institute

Ministero dell’Istruzione, dell’Università e della Ricerca

National Institutes of Health

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference40 articles.

1. GPCR inhibition in treating lymphoma;Barreca;ACS Med. Chem. Lett.,2022

2. An overview on anti-tubulin agents for the treatment of lymphoma patients;Barreca;Pharmacol. Ther.,2020

3. Adult non-Hodgkin lymphoma treatment (PDQ®): Health professional version. 2022 Jul 6,2002